Aziridination Using Copper Complexes
J . Org. Chem., Vol. 67, No. 10, 2002 3457
[Cu 2L32][OTf]2. (()-L3 (12.5 mg, 25.0 µmol) and (CuOTf)2‚
C6H6 (6.0 mg, 12 µmol) were dissolved in d2-dichloromethane.
After NMR analysis, concentration of the solution resulted in
formation of crystals suitable for X-ray diffraction. Drying in
vacuo caused complete loss of the solvent of crystallization.
1H NMR (CD2Cl2; δ): 1.12 (s, 36H), 1.73 (s, 12H), 7.00 (d, 8H,
J ) 8.3 Hz), 7.15 (d, 8H, J ) 7.5 Hz), 7.19 (t, 4H, J ) 7.5 Hz),
7.42 (d, 8H, J ) 8.3 Hz), 7.26 (s, C6H6), 8.62 (s, 4H). 13C NMR
(CD2Cl2; δ): 20.4, 31.4, 129.1 (C6H6), 122.0, 126.8, 129.7, 129.9,
130.8, 132.0, 133.1, 140.3, 160.7, 149.6, 173.0. MS (EI+; m/z):
712 [{CuIL3}][OTf]+, 500 [L3]+, 485 [L3 - CH3+]. MS (CI+;
m/z): 713 [CuIL3][OTf][H] +, 649 [(M+) - Cu], 563 [CuIL3]+,
485 [L3 - CH3+], 340 [L3 - NdCHC6H4C(CH3)3+]. MS (FAB+;
N-(p-Tolylsu lfon yl)-2-ca r bo-ter t-bu toxy-3-p h en yla zir i-
d in e (6a ). Pale, off-white solid. Yield: 144 mg, 77%. Mp: 55-
57 °C. IR (NaCl plates; νmax, cm-1): 3026, 2981, 2937, 1739,
1600, 1350, 1160, 1084, 909. 1H NMR (CDCl3; δ): 1.47 (s, 9H),
2.34 (s, 3H), 3.34 (d, 1H, J ) 4.0 Hz), 4.31 (d, 1H, J ) 4.0 Hz),
7.19 (m, 5H), 7.73 (d, 2H, J ) 8.3 Hz). 13C NMR (CDCl3; δ):
20.6, 26.8, 46.6, 47.7, 82.5, 126.2, 126.4, 127.5, 127.7, 128.5,
132.1, 136.6, 143.1, 163.6. MS (CI; m/z): 391 (M + NH4+), 374
1
(M + H+). Enantiomeric excess determined by H NMR using
Eu(hfc)3; ee ) 89%. [R]D25 ) -49.2° (c 1.00, CH2Cl2).7 Crystals
obtained were suitable for X-ray structural determination (see
Supporting Information).
N-(p -Tolylsu lfon yl)-2-ca r b o-ter t-b u t oxy-3-((4-m et h yl-
oxy)p h en yl)a zir id in e (6b). Yellow oil. Yield: 136.7 mg, 67%.
IR (NaCl plates; νmax, cm-1): 2977, 2927, 1746, 1614, 1516,
m/z): 1277 ([Cu2L32][OTf]+), 1128 [Cu2L3 +], 1063 [CuL32].
2
High-resolution MS (EI+): calcd mass (M+) 712.200 774, found
712.193 039. Anal. Calcd for C74H80Cu2F6N4O6S2: C, 62.30; H,
5.65; N, 3.93. Found: C, 62.30; H, 6.00; N, 4.15.
1
1368, 1332, 1253, 1161, 1091, 1032, 816. H NMR (CDCl3; δ):
1.15 (s, 9H), 2.42 (s, 3H), 3.56 (d, 1H, J ) 7.6 Hz), 3.74 (s,
3H), 4.29 (d, 1H, J ) 7.6 Hz), 6.78 (dd, 2H, J ) 6.7, 1.8 Hz),
7.22 (dd, 2H, J ) 6.7, 1.8 Hz), 7.33 (d, 2H, J ) 8.2 Hz), 7.90
(d, 2H, J ) 8.2 Hz). 13C NMR (CDCl3; δ): 22.1, 28.1, 44.7, 45.2,
55.7, 83.7, 113.9, 128.4, 129.2, 130.2, 164.0. MS (EI; m/z): 403
(M+), 347(M - C4H8+), 330 (M - OC4H9). HRMS (CI; m/z):
[Cu 2L42][OTf]2. (()-L4 (12.0 mg, 24.6 µmol) and (CuOTf)2‚
C6H6 (6.0 mg, 12 µmol) were dissolved in d2-dichloromethane.
Concentration of the solution resulted in the formation of
crystals suitable for X-ray diffraction. 1H NMR (CD2Cl2; δ):
1.96 (s, 12H), 6.64 (d, 4H, J ) 8.6 Hz), 6.84 (d, 4H, J ) 8.7
Hz), 7.06 (d, 4H, J ) 7.9 Hz), 7.26 (s, C6H6), 7.74 (s, 4H), 7.38-
7.14 (m, 16H), 8.77 (s, 4H). 13C NMR (CD2Cl2; δ): 20.7, 121.7,
122.3, 128.0, 128.4, 129.1, 129.2, 129.4, 129.6, 130.5, 132.4,
132.6, 133.1, 136.3, 149.9, 140.5, 164.9, 174.0. MS (FAB+;
m/z): 1253 ([{CuL4}2][OTf]+), 1104 ([{CuL4}2]+), 1040
([(CuL4)2]+), 552 ([CuL4]+). Anal. Calcd for C74H56Cu2F6-
N4O6S2: C, 63.37; H, 4.02; N, 3.99. Found: C, 63.30; H, 4.10;
N, 3.95.
404.1534, calcd [M+ + 1] 404.1550. Anal. Calcd for C21H25
-
NO5S: C, 62.51; H, 6.25; N, 3.47. Found: C, 62.49; H, 6.32;
N, 3.37. Enantiomeric excess determined by HPLC: Chiralcel
OD, 15 cm × 0.46 cm i.d.; mobile phase hexane/propan-2-ol
(95:5), tr(major) ) 16.41 min, tr(minor) ) 20.17 min, ee ) 93%.
26
[R]D ) +30.4° (c 1.06, CH2Cl2).
N-(p-Tolylsulfonyl)-2-carbo-tert-butoxy-3-(4-methylphen-
yl)a zir id in e (6c). Yellow oil. Yield: 114.3 mg, 59%. IR (NaCl
plates; νmax, cm-1): 2978, 2931, 1738, 1597, 1336, 1162, 1088,
[Cu L5][OTf]. (R)-L5 (15.0 mg, 25.5 µmol) and (CuOTf)2‚C6H6
(6.0 mg, 12 µmol) were dissolved in d2-dichloromethane. 1H
NMR (CD2Cl2; δ): 2.06 (s, 6H), 7.23 (s, C6H6), 6.79-8.11 (m,
26H), 9.38 (s, 2H). 13C NMR (CD2Cl2; δ): 20.5, 119.9, 123.0,
124.7, 125.0, 128.4, 129.0, 129.1 (C6H6), 129.2, 130.5, 130.8,
131.1, 131.3, 131.4, 132.8, 135.9, 139.9, 149.6, 164.4, 169.2.
MS (FAB+; m/z): 651 ([CuL5]+). IR (CD2Cl2; ν, cm-1): 3485,
3054, 1666, 1623, 1606, 1553, 1446, 1261, 1235, 1173, 1030,
954, 896, 736.
Gen er a l P r oced u r e for Azir id in a tion . A round-bottom
flask with a sidearm incorporating a PTFE stopcock was
charged with the metal salt (5 mol %) and the diimine ligand
(6 mol %) and was flushed with argon. Solvent (6 mL), usually
dichloromethane, was added, and the resulting mixture was
stirred for 15 min. Reactions were performed at room tem-
perature or in a bath of 2-propanol cooled to -40 °C using an
immersion cooler. The olefin (1-5 equiv) was added to the
stirred solution either via syringe or by solid addition against
a slow positive flow of argon. The solid nitrene source (1 equiv)
was added in a similar manner in a single portion to the stirred
solution. The reaction mixture was quenched by dilution with
hexane and was filtered through a small plug of silica. The
mixture was then concentrated to dryness on silica and
separated by flash chromatography. The product was identified
by NMR spectroscopy. Cis/ trans ratios were calculated from
1H NMR spectroscopy, and enantiomeric excesses (if ap-
plicable) were determined using (+)-Eu(hfc)3 as the chiral shift
reagent or by chiral HPLC on a Chiracel OD column, as
appropriate.
P r ep a r a tion of Azir id in es. N-(p-Tolylsu lfon yl)-2,3-(6-
a cetyl-2,2-d im eth ylch r om a n -3,4-yl)a zir id in e (4). White
solid. Yield: 79%. Mp (DSC): 160 °C. 1H NMR (CDCl3; δ): 1.25
(s, 3H), 1.31 (s, 3H), 2.43 (s, 3H), 2.54 (s, 3H), 3.37 (d, 1H, J )
7.3 Hz), 3.97 (d, 1H, J ) 7.3 Hz), 6.81 (d, 1H, J ) 8.4 Hz),
7.33 (d, 2H, J ) 8.1 Hz), 7.85-7.82 (m, 3H), 7.93 (s, 1H). 13C
NMR (CDCl3; δ): 19.6, 21.7, 23.8, 24.3, 37.6, 47.6, 70.9, 115.9,
116.3, 126.0, 127.7, 128.0, 128.8, 128.9, 132.7, 142.9, 154.8,
194.2. IR (Nujol; ν, cm-1): 1669, 1456, 1377, 1365, 1328, 1267,
1160, 904, 868, 830, 825. MS (EI+; m/z): 372 (M + H+), 216
(M+ - SO2C6H4CH3), 91 (C6H4CH3+), 43 (CH3CO+). High-
resolution MS (EI+): calcd mass (M+ - Ts) 216.102 454, found
216.101 996. Anal. Calcd for C20H21NO4S: C, 64.67; H, 5.70;
N, 3.77. Found: C, 64.48; H, 5.74; N, 3.61. Chiral HPLC
analysis (hexane/IPA (90:10), 1 mL/min): tr ) 14.9 min (major),
18.8 min (minor).
1
921, 813, 677. H NMR (CDCl3; δ): 1.46 (s, 9H), 2.24 (s, 3H),
2.33 (s, 3H), 3.35 (d, 1H, J ) 4.0 Hz), 4.26 (d, 1H, J ) 4.0 Hz),
7.05 (m, 4H),7.19 (d, 2H, J ) 8.5 Hz), 7.71 (d, 2H, J ) 8.5 Hz).
13C NMR (CDCl3; δ): 21.6, 22.0, 28.2, 48.2, 48.7, 83.8, 127.6,
127.7, 129.6, 129.9, 130.3, 138.1, 139.1, 144.4, 165.1. MS (EI;
m/z): 387 (M+), 332 (M - C4H8). HRMS (CI; m/z): found
388.1589, calcd [M+ + 1] 388.1601. Anal. Calcd for C21H25
-
NO4S: C, 65.09; H, 6.50; N, 3.61. Found: C, 64.98; H, 6.29;
N, 3.53. Enantiomeric excess determined by 1H NMR using
30
Eu(hfc)3, ee ) 88%. [R]D ) -18.9° (c 0.84, CH2Cl2).
N-(p-Tolylsulfonyl)-2-carbo-tert-butoxy-3-(3-methylphen-
yl)a zir id in e (6d ). Yellow oil. Yield: 109 mg, 56%. IR (NaCl
plates; νma, cm-1):x 2979, 2926, 1736, 1638, 1337, 1163, 1087,
1
784, 690. H NMR (CDCl3; δ): 1.53 (s, 9H), 2.28 (s, 3H), 2.40
(s, 3H), 3.39 (d, 1H, J ) 4.0 Hz), 4.31 (d, 1H, J ) 4.0 Hz),
6.99-7.28 (m, 6 H), 7.78 (d, 2H, J ) 8.6 Hz). 13C NMR (CDCl3;
δ): 20.8, 20.6, 26.8, 46.6, 47.5, 82.4, 123.2, 126.4, 127.0, 127.4,
128.5, 128.5, 132.0, 136.5, 137.3, 143.0, 163.6. MS (CI; m/z):
405 (M + NH4+), 388 (M + H+). HRMS (CI; m/z): found
388.1581, calcd [M+ + 1] 388.1601. Anal. Calcd for C21H25
-
NO4S: C, 65.09; H, 6.50; N, 3.61. Found: C, 65.11; H, 6.59;
N, 3.67. Enantiomeric excess determined by 1H NMR using
28
Eu(hfc)3, ee ) 96%. [R]D ) -19.9° (c 0.24, CH2Cl2).
N-(p-Tolylsu lfon yl)-2-car bo-ter t-bu toxy-3-(4-flu or oph en -
yl)a zir id in e (6e). Yellow oil. Yield: 130.0 mg, 66%. IR (NaCl
plates; νmax, cm-1): 2982, 1732, 1608, 1515, 1336, 1222, 1088,
1
925, 814, 738, 690. H NMR (CDCl3; δ): 1.52 (s, 9H), 2.40 (s,
3H), 3.39 (d, 1H, J ) 4.0 Hz), 4.33 (d, 1H, J ) 4.0 Hz), 6.97
(dd, 2H, J ) 8.5 Hz), 7.17-7.28 (m, 4H), 7.77 (d, 2H, J ) 8.5
Hz). 13C NMR (CDCl3; δ): 20.6, 26.8, 45.9, 47.5, 82.6, 114.4,
114.7, 126.5, 128.0, 128.1, 128.5, 136.4, 143.2, 163.5. MS (CI;
m/z): 409 (MNH4+), 392 (MH+). HRMS (CI; m/z): found
392.1337, calcd [M+ + 1] 392.1351. Anal. Calcd for C20H22
-
FNO4S: C, 61.36; H, 5.66; N, 3.58. Found: C, 61.48; H, 5.29;
N, 3.73. Enantiomeric excess determined by HPLC: Chiralcel
OD, 15 cm × 0.46 cm i.d.; mobile phase hexane/propan-2-ol
(95:5), tr(major) ) 15.56 min, tr(minor) ) 19.37 min, ee ) 98%,
30
[R]D ) -42.2° (c 0.25, CH2Cl2).
N-(p-Tolylsu lfon yl)-2-car bo-ter t-bu toxy-3-(4-ch lor oph en -
yl)a zir id in e (6f). Yellow oil. Yield: 174 mg, 89%. IR (NaCl
plates; νmax, cm-1): 2980, 2931, 1738, 1598, 1495, 1339, 1164,
1090, 915, 814, 731, 686. 1H NMR (CDCl3; δ): 1.52 (s, 9H),
2.40 (s, 3H), 3.36 (d, 1H, J ) 4.0 Hz), 4.32 (d, 1H, J ) 4.0 Hz),
7.15 (dd, 2H, J ) 8.9 Hz),7.17-7.28 (m, 4H), 7.77 (d, 2H, J )